Bank of Montreal
BNGO icon

Bank of Montreal’s Bionano Genomics BNGO Stock Holding History

Bank of Montreal’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30
Closed -$20.3K – 3985
2023
Q1 		$20.3K Sell
30
-73
-71% -$64.8K ﹤0.01% 3530
2022
Q4 		$92K Buy
103
+1
+1% +$1.26K ﹤0.01% 3382
2022
Q3 		$115 Sell
102
-2
-2% -$2.64K ﹤0.01% 3420
2022
Q2 		$93 Buy
104
+6
+6% +$6.17K ﹤0.01% 3474
2022
Q1 		$159K Sell
98
-295
-75% -$398K ﹤0.01% 3538
2021
Q4 		$736K Buy
+393
New +$1.05M ﹤0.01% 2136
2021
Q2 		– Sell
-17
Closed -$77K – 3799
2021
Q1 		$77K Buy
17
+15
+750% +$84.6K ﹤0.01% 3516
2020
Q4 		$6K Sell
2
-1
-33% -$374 ﹤0.01% 4735
2020
Q3 		$1K Buy
+3
New +$1.16K ﹤0.01% 4679

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal's BNGO Position: Q2 2023 in Review

Bank of Montreal sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 30 shares — an estimated $20.3K sold.

Bank of Montreal first reported a position in BNGO in Q3 2020 and held it in 9 quarters. The position peaked at $736K in Q4 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Bank of Montreal reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Bank of Montreal sold 30 Bionano Genomics shares in Q2 2023, an estimated $20.3K.
  • Bank of Montreal first reported a position in Bionano Genomics in Q3 2020 and held it in 9 quarters.
  • Bank of Montreal's Bionano Genomics position peaked at $736K in Q4 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.